Hybrid Cell Membrane-Functionalized Nanoagents Synergistically Enhance Cuproptosis-Mediated Immunotherapy by Dual Modulation of Glycolytic Metabolism and Tumor Microenvironments
ACS Nano · 2025
DOI: 10.1021/acsnano.5c10671 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Qiang Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, 30 Zhongyang Road, Nanjing, Jia…. Hauptthemen laut MEDLINE: Glycolysis, Immunotherapy, Tumor Microenvironment, Copper. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Nanjing Medical Science and Technique Development Foundation.
Abstract (Originalsprache)
Glycolytic activity of cancer cells not only reduces their vulnerability to cuproptosis but also heightens the immunosuppressive state of the tumor microenvironment (TME). Our study introduces a nanoplatform called dual-remodeling cuproptosis-inducing agent with hybrid cell membrane coating (DREAM), which is crafted to simultaneously modify the metabolic and immunological landscapes of the TME to enhance cuproptosis-driven immunotherapy. This platform exploits cancer-cell-derived membranes for homologous targeting, enhancing tumor specificity, intratumoral penetration, and intracellular copper delivery. DREAM’s disruption of glycolysis intensifies the copper overload, triggering cuproptosis in cancer cells. Additionally, it alleviates immunosuppression and bolsters immune responses facilitated by the immunogenic cell death from cuproptosis, further potentiated by the immunostimulatory effect of M1 macrophage membranes. The outcome is a pronounced efficacy in curbing tumor growth and distant metastasis in squamous cell carcinoma and also in suppressing melanoma proliferation and lung metastasis. This research underscores the vital interaction among inhibiting glycolysis, enhancing sensitivity to cuproptosis, and activating immune responses, thereby paving a feasible and integrated pathway in cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, 30 Zhongyang Road, Nanjing, Jiangsu 210008, China.
- Institute for Health Innovation & Technology, Biomedical Engineering Department, National University of Singapore, 21 Lower Kent Ridge Road, Singapore 119276, Singapore.
- Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Pl, New York, New York 10029, United States.
- State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergistic Innovation Center for Advanced Materials…
ORCID-Profile: Zhusheng Huang, Lianhui Wang, Heng Dong
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Nanjing Medical Science and Technique Development Foundation
- Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University
- Nanjing Clinical Research Center for Oral Diseases
Zitieren
APA
Li, Q., Dang, M., He, A., Li, X., Ding, M., Dai, Z., Zhang, Y., Xiu, W., Wang, S., Huang, Z., Mou, Y., Wang, L., & Dong, H. (2025). Hybrid Cell Membrane-Functionalized Nanoagents Synergistically Enhance Cuproptosis-Mediated Immunotherapy by Dual Modulation of Glycolytic Metabolism and Tumor Microenvironments. ACS Nano. https://doi.org/10.1021/acsnano.5c10671
Vancouver
Li Q, Dang M, He A, Li X, Ding M, Dai Z, et al. Hybrid Cell Membrane-Functionalized Nanoagents Synergistically Enhance Cuproptosis-Mediated Immunotherapy by Dual Modulation of Glycolytic Metabolism and Tumor Microenvironments. ACS Nano. 2025. doi:10.1021/acsnano.5c10671
BibTeX
@article{Li2025,
author = {Li, Qiang and Dang, Meng and He, Ao and Li, Xiaoye and Ding, Meng and Dai, Zhuo and Zhang, Yu and Xiu, Weijun and Wang, Siyu and Huang, Zhusheng and Mou, Yongbin and Wang, Lianhui and Dong, Heng},
title = {Hybrid Cell Membrane-Functionalized Nanoagents Synergistically Enhance Cuproptosis-Mediated Immunotherapy by Dual Modulation of Glycolytic Metabolism and Tumor Microenvironments},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.5c10671}
}
EUVIMED